Literature DB >> 8039846

Coronary artery constriction caused by the cold pressor test in human hypertension.

I Antony1, E Aptecar, G Lerebours, A Nitenberg.   

Abstract

Hypertensive patients with angiographically normal coronary arteries may have myocardial ischemia when metabolic demand increases. Abnormal epicardial coronary artery vasomotion in response to sympathetic stimulation may contribute to ischemia in such patients. We studied the vasomotor response of smooth coronary arteries to a cold pressor test in 10 hypertensive patients without other risk factors and in 9 control subjects. Vessel dimensions were measured by quantitative angiography, and blood flow was calculated using an intracoronary Doppler catheter in the left anterior descending coronary artery. In response to cold pressor stimulation, arteries of control subjects dilated 13.0 +/- 5.9% (P < .001), and they constricted 8.2 +/- 8.5% in hypertensive patients (P < .001). Rate-pressure product increased from 9466 +/- 1677 to 12,547 +/- 2367 beats per minute (bpm).mm Hg in control subjects (P < .001) and from 13,720 +/- 1823 to 17,353 +/- 2037 bpm.mm Hg in hypertensive patients (P < .001). Coronary blood flow velocity and blood flow increased 51 +/- 26% (P < .05) and 87 +/- 27% (P < .001), respectively, in control subjects and 68 +/- 52% (P < .05) and 36 +/- 33% (P < .01) in hypertensive patients. At peak cold pressor test, despite a significant higher rate-pressure product in hypertensive patients, blood flow was similar in both groups, suggesting an uncoupling between myocardial metabolic demand and supply. Thus, hypertension impairs the vasodilator response of angiographically normal coronary arteries to a cold pressor test. This abnormal response may be due to enhanced catecholamine reactivity and/or impairment of endothelial flow-mediated vasodilator response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8039846     DOI: 10.1161/01.hyp.24.2.212

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

1.  Long-term cigarette smoking is associated with increased myocardial perfusion heterogeneity assessed by positron emission tomography.

Authors:  J G Meeder; P K Blanksma; E E van der Wall; R L Anthonio; A T Willemsen; J Pruim; W Vaalburg; K I Lie
Journal:  Eur J Nucl Med       Date:  1996-11

2.  Contribution of sympathetic activation to coronary vasodilatation during the cold pressor test in healthy men: effect of ageing.

Authors:  Kevin D Monahan; Robert P Feehan; Lawrence I Sinoway; Zhaohui Gao
Journal:  J Physiol       Date:  2013-03-11       Impact factor: 5.182

3.  Altered coronary endothelial function in young smokers detected by magnetic resonance assessment of myocardial blood flow during the cold pressor test.

Authors:  Yasutaka Ichikawa; Kakuya Kitagawa; Shingo Kato; Kaoru Dohi; Tadanori Hirano; Masaaki Ito; Hajime Sakuma
Journal:  Int J Cardiovasc Imaging       Date:  2014-02-12       Impact factor: 2.357

Review 4.  [The role of endothelial function for ischemic manifestations of coronary atherosclerosis].

Authors:  M Britten; V Schächinger
Journal:  Herz       Date:  1998-03       Impact factor: 1.443

5.  Contrasting effects of verapamil and amlodipine on cardiovascular stress responses in hypertension.

Authors:  J D Lefrandt; J Heitmann; K Sevre; M Castellano; M Hausberg; M Fallon; A Urbigkeit; M Rostrup; E Agabiti-Rosei; K H Rahn; M Murphy; F Zannad; P J de Kam; A J Smit
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

6.  Abnormal myocardial perfusion and contractile recruitment during exercise in type 1 diabetic patients.

Authors:  Roldano Scognamiglio; Christian Negut; Saula Vigili de Kreuizenberg; Monica Palisi; Antonio Tiengo; Angelo Avogaro
Journal:  Clin Cardiol       Date:  2005-02       Impact factor: 2.882

Review 7.  The Background of Calculating CAVI: Lesson from the Discrepancy Between CAVI and CAVI0.

Authors:  Koji Takahashi; Tomoyuki Yamamoto; Shinichi Tsuda; Mitsuya Maruyama; Kohji Shirai
Journal:  Vasc Health Risk Manag       Date:  2020-05-21

Review 8.  Noninvasive assessment of preclinical atherosclerosis.

Authors:  Helen A Lane; Jamie C Smith; J Stephen Davies
Journal:  Vasc Health Risk Manag       Date:  2006
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.